Lanean...
Riociguat: Something new in pulmonary hypertension therapeutics?
Pulmonary hypertension (PH) continues to be a disease that is associated with woeful outcomes. The search for an ideal drug molecule for PH led to the discovery of riociguat, which is a first-in-class drug molecule that activates soluble guanylate cyclase. We conducted a systematic literature search...
Gorde:
| Argitaratua izan da: | J Pharmacol Pharmacother |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Medknow Publications & Media Pvt Ltd
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319244/ https://ncbi.nlm.nih.gov/pubmed/25709345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.149132 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|